Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 34

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets

Ramzy, Adam, Belmonte, Paul J, Braam, Mitchell J S, Ida, Shogo, Wilts, Emily M, Levings, Megan K, Rezania, Alireza, Kieffer, Timothy J·2023·Endocrine Reviews

Abstract

For the past century, insulin injections have saved millions of lives, but glycemic instability is still a persistent challenge for people with diabetes, leading to tremendous morbidity and premature mortality. Research in the field of islet transplantation has demonstrated that replacing insulin-producing β cells can restore euglycemia comparable to individuals without diabetes. However, a short supply of cadaveric islet donors, the technically challenging process of isolating islets, and the requirement for chronic immune suppression have impeded widespread clinical adoption. Rather than relying on cadaveric cells, pluripotent stem cells could serve as a virtually unlimited supply of insulin-producing β cells. Protocols have been developed that mimic the normal in vivo development of the human pancreas to generate pancreatic progenitor cells in vitro. Ongoing investigations have yielded progressively more mature β-like cells in vitro that produce insulin but do not yet fully mimic healthy mature β cells. Alongside development of differentiation protocols, other work has provided insight into potential implantation sites for stem cell–derived islet cells including the subcutaneous space, portal vein, and omentum. To optimize implanted cell survival and function, development of immune modulation therapies is ongoing, including selection of immunomodulatory medications and genetic modification of implanted cells to evade immune responses. Further, macroencapsulation or microencapsulation devices could be used to contain and/or immunoprotect implanted cells from the immune response including by using 3-dimensional bioprinting to facilitate the process. Remarkably, ongoing clinical trials have now yielded the first patient relying on differentiated stem cells rather than syringes as their insulin replacement therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endrev/bnac021

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 317

  1. International Diabetes Foundation, 2021, IDF Diabetes Atlas
  2. Aleksandrovski, 1998, Molecular mechanisms of diabetic complications, Biochemistry (Mosc)., 63, 1249
  3. Olehnik, 2017, Quantitative analysis of intra- and inter-individual variability of human beta-cell mass, Sci Rep, 7, 16398, 10.1038/s41598-017-16300-w · DOI
  4. Ionescu-Tirgoviste, 2015, A 3D map of the islet routes throughout the healthy human pancreas, Sci Rep, 5, 14634, 10.1038/srep14634 · DOI · Paper page
  5. Schuit, 1991, Measuring the balance between insulin synthesis and insulin release, Biochem Biophys Res Commun, 178, 1182, 10.1016/0006-291X(91)91017-7 · DOI
  6. Liu, 2018, Biosynthesis, structure, and folding of the insulin precursor protein, Diabetes Obes Metab, 20, 28, 10.1111/dom.13378 · DOI · Paper page
  7. Walker, 2021, The human islet: mini-organ with mega-impact, Endocr Rev, 42, 605, 10.1210/endrev/bnab010 · DOI
  8. Freckmann, 2007, Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals, J Diabetes Sci Technol, 1, 695, 10.1177/193229680700100513 · DOI · Paper page
  9. Bentsi-Barnes, 2011, Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function, Islets, 3, 284, 10.4161/isl.3.5.15938 · DOI
  10. Rorsman, 2003, Insulin granule dynamics in pancreatic beta cells, Diabetologia, 46, 1029, 10.1007/s00125-003-1153-1 · DOI · Paper page
  11. Holst, 2007, The physiology of glucagon-like peptide 1, Physiol Rev, 87, 1409, 10.1152/physrev.00034.2006 · DOI · Paper page
  12. McIntosh, 2012, Glucose-dependent insulinotropic polypeptide signaling in pancreatic beta-cells and adipocytes, J Diabetes Investig, 3, 96, 10.1111/j.2040-1124.2012.00196.x · DOI
  13. Schuit, 1985, Regulation of adenosine 3’,5'-monophosphate levels in the pancreatic B cell, Endocrinology, 117, 834, 10.1210/endo-117-3-834 · DOI
  14. Pipeleers, 1985, Interplay of nutrients and hormones in the regulation of insulin release, Endocrinology, 117, 824, 10.1210/endo-117-3-824 · DOI · Paper page
  15. Chambers, 2017, The role of pancreatic preproglucagon in glucose homeostasis in mice, Cell Metab, 25, 927, 10.1016/j.cmet.2017.02.008 · DOI · Paper page
  16. Dai, 2022, Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation state, Cell Metab, 34, 256, 10.1016/j.cmet.2021.12.021 · DOI
  17. Salehi, 2007, Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon, Regul Pept, 144, 43, 10.1016/j.regpep.2007.06.003 · DOI
  18. Kailey, 2012, SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells, Am J Physiol Endocrinol Metab, 303, E1107, 10.1152/ajpendo.00207.2012 · DOI · Paper page
  19. Swayne, 2009, The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic beta-cell line, EMBO Rep, 10, 873, 10.1038/embor.2009.125 · DOI
  20. Thomas, 2018, Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank, Lancet Diabetes Endocrinol, 6, 122, 10.1016/S2213-8587(17)30362-5 · DOI · Paper page
  21. Brown, 2001, All-cause mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population, Diabetes Care, 24, 56, 10.2337/diacare.24.1.56 · DOI
  22. Mohan, 2011, Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion, J Exp Med, 208, 2375, 10.1084/jem.20111502 · DOI
  23. Mohan, 2013, Pathogenic CD4+ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes, J Exp Med, 210, 2403, 10.1084/jem.20130582 · DOI
  24. Carrero, 2017, Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice, Proc Natl Acad Sci U S A, 114, E10418, 10.1073/pnas.1713543114 · DOI · Paper page
  25. Pugliese, 2017, Autoreactive T cells in type 1 diabetes, J Clin Invest, 127, 2881, 10.1172/JCI94549 · DOI · Paper page
  26. Wan, 2018, Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides, Nature, 560, 107, 10.1038/s41586-018-0341-6 · DOI
  27. Jeker, 2012, Breakdown in peripheral tolerance in type 1 diabetes in mice and humans, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a007807 · DOI
  28. Fan, 2009, Thymus-specific deletion of insulin induces autoimmune diabetes, EMBO J, 28, 2812, 10.1038/emboj.2009.212 · DOI · Paper page
  29. Soleimanpour, 2013, The pancreatic beta cell and type 1 diabetes: innocent bystander or active participant?, Trends Endocrinol Metab, 24, 324, 10.1016/j.tem.2013.03.005 · DOI
  30. Norris, 2020, Type 1 diabetes-early life origins and changing epidemiology, Lancet Diabetes Endocrinol, 8, 226, 10.1016/S2213-8587(19)30412-7 · DOI · Paper page
  31. Lee, 2011, Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion, Proc Natl Acad Sci U S A, 108, 8885, 10.1073/pnas.1105564108 · DOI · Paper page
  32. Xie, 2002, Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation, Hepatology, 36, 592, 10.1053/jhep.2002.35441 · DOI · Paper page
  33. Engin, 2013, Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes, Sci Transl Med, 5, 10.1126/scitranslmed.3006534 · DOI · Paper page
  34. Lee, 2020, Beta cell dedifferentiation induced by IRE1alpha deletion prevents type 1 diabetes, Cell Metab, 31, 822, 10.1016/j.cmet.2020.03.002 · DOI · Paper page
  35. Ilonen, 2019, The heterogeneous pathogenesis of type 1 diabetes mellitus, Nat Rev Endocrinol, 15, 635, 10.1038/s41574-019-0254-y · DOI · Paper page
  36. Gujral, 2013, Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations, Ann N Y Acad Sci, 1281, 51, 10.1111/j.1749-6632.2012.06838.x · DOI · Paper page
  37. Petersen, 2006, Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men, Proc Natl Acad Sci U S A, 103, 18273, 10.1073/pnas.0608537103 · DOI · Paper page
  38. Voight, 2010, Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis, Nat Genet, 42, 579, 10.1038/ng.609 · DOI · Paper page
  39. Mahajan, 2018, Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes, Nat Genet, 50, 559, 10.1038/s41588-018-0084-1 · DOI · Paper page
  40. Diabetes Canada Clinical Practice Guidelines Expert Committee, 2018, Pharmacologic glycemic management of type 2 diabetes in adults, Can J Diabetes, 42, S88
  41. Gruessner, 2016, Pancreas transplantation of US and Non-US cases from 2005 to 2014 as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR), Rev Diabet Stud, 13, 35, 10.1900/RDS.2016.13.35 · DOI · Paper page
  42. Boland, 2019, Pancreatic β-cell rest replenishes insulin secretory capacity and attenuates diabetes in an extreme model of obese type 2 diabetes, Diabetes, 68, 131, 10.2337/db18-0304 · DOI
  43. Aguilar-Bryan, 2008, Neonatal diabetes mellitus, Endocr Rev, 29, 265, 10.1210/er.2007-0029 · DOI · Paper page
  44. Firdous, 2018, Genetic testing of maturity-onset diabetes of the young current status and future perspectives, Front Endocrinol (Lausanne), 17, 253, 10.3389/fendo.2018.00253 · DOI
  45. McIntyre, 2019, Gestational diabetes mellitus, Nat Rev Dis Primers, 5, 47, 10.1038/s41572-019-0098-8 · DOI · Paper page
  46. Flier, 2019, Starvation in the midst of plenty: reflections on the history and biology of insulin and leptin, Endocr Rev, 40, 1, 10.1210/er.2018-00179 · DOI
  47. Karamitsos, 2011, The story of insulin discovery, Diabetes Res Clin Pract, 93, S2, 10.1016/S0168-8227(11)70007-9 · DOI
  48. Cox, 2011, Elizabeth Evans Hughes—surviving starvation therapy for diabetes, Lancet, 377, 1232, 10.1016/S0140-6736(11)60490-X · doi:10.1016/s0140-6736(11)60490-x
  49. Russell, 2015, 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications, Diabetologia, 58, 1708, 10.1007/s00125-015-3600-1 · DOI
  50. Hirsch, 2020, The evolution of insulin and how it informs therapy and treatment choices, Endocr Rev, 41, 733, 10.1210/endrev/bnaa015 · DOI · Paper page
  51. Goeddel, 1979, Expression in Escherichia coli of chemically synthesized genes for human insulin, Proc Natl Acad Sci U S A, 76, 106, 10.1073/pnas.76.1.106 · DOI · Paper page
  52. Mathieu, 2017, Insulin analogues in type 1 diabetes mellitus: getting better all the time, Nat Rev Endocrinol, 13, 385, 10.1038/nrendo.2017.39 · DOI · Paper page
  53. DeVries, 2002, A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control, Diabetes Care, 25, 2074, 10.2337/diacare.25.11.2074 · DOI · Paper page
  54. Schade, 2002, To pump or not to pump, Diabetes Care, 25, 2100, 10.2337/diacare.25.11.2100 · DOI
  55. Boughton, 2019, Advances in artificial pancreas systems, Sci Transl Med, 11, 10.1126/scitranslmed.aaw4949 · DOI
  56. Lewis, 2019, History and perspective on DIY closed looping, J Diabetes Sci Technol, 13, 790, 10.1177/1932296818808307 · DOI
  57. Kulcu, 2003, Physiological differences between interstitial glucose and blood glucose measured in human subjects, Diabetes Care, 26, 2405, 10.2337/diacare.26.8.2405 · DOI · Paper page
  58. Ekberg, 2003, Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes, Diabetes, 52, 536, 10.2337/diabetes.52.2.536 · DOI · Paper page
  59. Schmitz, 2004, Amylin agonists: a novel approach in the treatment of diabetes, Diabetes, 53, S233, 10.2337/diabetes.53.suppl_3.S233 · DOI · Paper page
  60. Ekberg, 2007, C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy, Diabetes Care, 30, 71, 10.2337/dc06-1274 · DOI · Paper page
  61. Pullen, 2021, Islet cell transplantation hits a milestone, Am J Transplant, 21, 2625, 10.1111/ajt.16039 · doi:10.1111/ajt.16039
  62. Kelly, 1967, Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy, Surgery, 61, 827
  63. Bahar, 2021, Pancreas Transplantation
  64. Gruessner, 2016, Long-term outcome after pancreas transplantation: a registry analysis, Curr Opin Organ Transplant, 21, 377, 10.1097/MOT.0000000000000331 · DOI
  65. Gruessner, 2014, Declining numbers of pancreas transplantations but significant improvements in outcome, Transplant Proc, 46, 1936, 10.1016/j.transproceed.2014.06.045 · DOI
  66. Stratta, 2016, Pancreas transplantation: an alarming crisis in confidence, Am J Transplant, 16, 2556, 10.1111/ajt.13890 · DOI
  67. Moskalewski, 1965, Isolation and culture of the islets of Langerhans of the guinea pig, Gen Comp Endocrinol, 5, 342, 10.1016/0016-6480(65)90059-6 · DOI · Paper page
  68. Lacy, 1967, Method for the isolation of intact islets of Langerhans from the rat pancreas, Diabetes, 16, 35, 10.2337/diab.16.1.35 · DOI · Paper page
  69. Ballinger, 1972, Transplantation of intact pancreatic islets in rats, Surgery, 72, 175
  70. Lindall, 1969, Immunoassayable insulin content of subcellular fractions of rat islets, Endocrinology, 85, 218, 10.1210/endo-85-2-218 · doi:10.1210/endo-85-2-218
  71. Horaguchi, 1981, Preparation of viable islet cells from dogs by a new method, Diabetes, 30, 455, 10.2337/diab.30.5.455 · DOI
  72. Largiadér, 1980, A long term functioning human pancreatic islet allotransplant, Transplantation, 29, 76, 10.1097/00007890-198001000-00017 · DOI
  73. Ricordi, 1988, Automated method for isolation of human pancreatic islets, Diabetes, 37, 413, 10.2337/diab.37.4.413 · DOI · Paper page
  74. Piemonti, 2013, 25 years of the Ricordi automated method for islet isolation, CellR4 Repair Replace Regen Reprogram, 1, e128
  75. Shapiro, 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen, N Engl J Med, 343, 230, 10.1056/NEJM200007273430401 · DOI · Paper page
  76. Shapiro, 2019, Islet transplantation—the Canadian perspective, CellR4 Repair Replace Regen Reprogram, 7, e2799
  77. Shapiro, 2017, Clinical pancreatic islet transplantation, Nat Rev Endocrinol, 13, 268, 10.1038/nrendo.2016.178 · DOI · Paper page
  78. Marfil-Garza, 2022, Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada, Lancet Diabetes Endocrinol, 10, 519, 10.1016/S2213-8587(22)00114-0 · DOI · Paper page
  79. Foster, 2018, Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia, Diabetes Care, 41, 1001, 10.2337/dc17-1779 · DOI
  80. Robertson, 2010, Islet transplantation a decade later and strategies for filling a half-full glass, Diabetes, 59, 1285, 10.2337/db09-1846 · DOI
  81. Zhong, 2019, Endogenous pancreatic β cell regeneration: a potential strategy for the recovery of β cell deficiency in diabetes, Front Endocrinol (Lausanne), 20, 101, 10.3389/fendo.2019.00101 · DOI
  82. Yang, 2020, A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of beta cells, Sci Adv, 6, eabc3207, 10.1126/sciadv.abc3207 · DOI
  83. Till, 1961, A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat Res, 14, 213, 10.2307/3570892 · DOI · Paper page
  84. Takahashi, 2013, Induced pluripotent stem cells in medicine and biology, Development, 140, 2457, 10.1242/dev.092551 · DOI · Paper page
  85. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  86. Kimura-Yoshida, 2005, Canonical Wnt signaling and its antagonist regulate anterior-posterior axis polarization by guiding cell migration in mouse visceral endoderm, Dev Cell, 9, 639, 10.1016/j.devcel.2005.09.011 · DOI · Paper page
  87. Jorgensen, 2007, An illustrated review of early pancreas development in the mouse, Endocr Rev, 28, 685, 10.1210/er.2007-0016 · DOI · Paper page
  88. McCracken, 2012, Molecular pathways controlling pancreas induction, Semin Cell Dev Biol, 23, 656, 10.1016/j.semcdb.2012.06.009 · DOI
  89. Geusz, 2021, Sequence logic at enhancers governs a dual mechanism of endodermal organ fate induction by FOXA pioneer factors, Nat Commun, 12, 6636, 10.1038/s41467-021-26950-0 · DOI
  90. Jennings, 2013, Development of the human pancreas from foregut to endocrine commitment, Diabetes, 62, 3514, 10.2337/db12-1479 · DOI · Paper page
  91. Ahlgren, 1996, The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice, Development, 122, 1409, 10.1242/dev.122.5.1409 · DOI · Paper page
  92. Sander, 2000, Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas, Development, 127, 5533, 10.1242/dev.127.24.5533 · DOI · Paper page
  93. Schaffer, 2010, Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors, Dev Cell, 18, 1022, 10.1016/j.devcel.2010.05.015 · DOI · Paper page
  94. Apelqvist, 1999, Notch signalling controls pancreatic cell differentiation, Nature, 400, 877, 10.1038/23716 · DOI · Paper page
  95. Gradwohl, 2000, Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas, Proc Natl Acad Sci U S A, 97, 1607, 10.1073/pnas.97.4.1607 · DOI · Paper page
  96. Villasenor, 2008, Biphasic Ngn3 expression in the developing pancreas, Dev Dyn, 237, 3270, 10.1002/dvdy.21740 · DOI
  97. Johansson, 2007, Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types, Dev Cell, 12, 457, 10.1016/j.devcel.2007.02.010 · DOI · Paper page
  98. Scavuzzo, 2018, Pancreatic cell fate determination relies on Notch ligand trafficking by NFIA, Cell Rep, 25, 3811, 10.1016/j.celrep.2018.11.078 · DOI
  99. Krentz, 2018, Single-cell transcriptome profiling of mouse and hESC-derived pancreatic progenitors, Stem Cell Rep, 11, 1551, 10.1016/j.stemcr.2018.11.008 · DOI
  100. Byrnes, 2018, Lineage dynamics of murine pancreatic development at single-cell resolution, Nat Commun, 9, 3922, 10.1038/s41467-018-06176-3 · DOI · Paper page
  101. Bastidas-Ponce, 2019, Comprehensive single cell mRNA profiling reveals a detailed roadmap for pancreatic endocrinogenesis, Development, 146, dev173849, 10.1242/dev.173849 · DOI · Paper page
  102. Salisbury, 2014, The window period of NEUROGENIN3 during human gestation, Islets, 6, e954436, 10.4161/19382014.2014.954436 · DOI
  103. Nair, 2015, Islet formation in mice and men: lessons for the generation of functional insulin-producing beta-cells from human pluripotent stem cells, Curr Opin Genet Dev, 32, 171, 10.1016/j.gde.2015.03.004 · DOI
  104. Ahlgren, 1997, Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells, Nature, 385, 257, 10.1038/385257a0 · DOI · Paper page
  105. Naya, 1997, Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice, Genes Dev, 11, 2323, 10.1101/gad.11.18.2323 · DOI · Paper page
  106. Collombat, 2005, The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas, Development, 132, 2969, 10.1242/dev.01870 · DOI · Paper page
  107. Collombat, 2003, Opposing actions of Arx and Pax4 in endocrine pancreas development, Genes Dev, 17, 2591, 10.1101/gad.269003 · DOI · Paper page
  108. Sussel, 1998, Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells, Development, 125, 2213, 10.1242/dev.125.12.2213 · DOI · Paper page
  109. Sander, 1997, Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development, Genes Dev, 11, 1662, 10.1101/gad.11.13.1662 · DOI · Paper page
  110. Ahmad, 2015, Pax6 inactivation in the adult pancreas reveals ghrelin as endocrine cell maturation marker, PLoS One, 10, e0144597, 10.1371/journal.pone.0144597 · DOI
  111. Gao, 2014, Pdx1 maintains beta cell identity and function by repressing an alpha cell program, Cell Metab, 19, 259, 10.1016/j.cmet.2013.12.002 · DOI · Paper page
  112. Herrera, 1991, Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene, Development, 113, 1257, 10.1242/dev.113.4.1257 · DOI · Paper page
  113. Vieira, 2017, β-Cell replacement strategies: the increasing need for a “β-cell dogma.”, Front Genet, 6, 75, 10.3389/fgene.2017.00075 · DOI
  114. van der Meulen, 2014, Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3, Rev Diabet Stud, 11, 115, 10.1900/RDS.2014.11.115 · DOI
  115. Xin, 2016, RNA sequencing of single human islet cells reveals type 2 diabetes genes, Cell Metab, 24, 608, 10.1016/j.cmet.2016.08.018 · DOI · Paper page
  116. Nishimura, 2015, MafA is critical for maintenance of the mature beta cell phenotype in mice, Diabetologia, 58, 566, 10.1007/s00125-014-3464-9 · DOI
  117. Aguayo-Mazzucato, 2011, Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells, Diabetologia, 54, 583, 10.1007/s00125-010-2026-z · DOI · Paper page
  118. Shrestha, 2021, Combinatorial transcription factor profiles predict mature and functional human islet α and β cells, JCI Insight, 6, e151621, 10.1172/jci.insight.151621 · DOI
  119. Bevacqua, 2021, SIX2 and SIX3 coordinately regulate functional maturity and fate of human pancreatic beta cells, Genes Dev, 35, 234, 10.1101/gad.342378.120 · DOI
  120. Romer, 2019, Murine perinatal β-cell proliferation and the differentiation of human stem cell-derived insulin-expressing cells require NEUROD1, Diabetes, 68, 2259, 10.2337/db19-0117 · DOI
  121. Yu, 2021, Sequential progenitor states mark the generation of pancreatic endocrine lineages in mice and humans, Cell Res, 31, 886, 10.1038/s41422-021-00486-w · DOI
  122. Yu, 2019, Defining multistep cell fate decision pathways during pancreatic development at single-cell resolution, EMBO J, 38, 10.15252/embj.2018100164 · DOI
  123. van Gurp, 2022, Generation of human islet cell type-specific identity genesets, Nat Commun, 13, 2020, 10.1038/s41467-022-29588-8 · DOI
  124. Muraro, 2016, A single-cell transcriptome atlas of the human pancreas, Cell Syst, 3, 385, 10.1016/j.cels.2016.09.002 · DOI · Paper page
  125. Qadir, 2020, Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche, Proc Natl Acad Sci U S A, 117, 10876, 10.1073/pnas.1918314117 · DOI · Paper page
  126. Assady, 2001, Insulin production by human embryonic stem cells, Diabetes, 50, 1691, 10.2337/diabetes.50.8.1691 · DOI · Paper page
  127. Rajagopal, 2003, Insulin staining of ES cell progeny from insulin uptake, Science, 299, 363, 10.1126/science.1077838 · DOI · Paper page
  128. Allegrucci, 2007, Differences between human embryonic stem cell lines, Hum Reprod Update, 13, 103, 10.1093/humupd/dml041 · DOI · Paper page
  129. Segev, 2004, Differentiation of human embryonic stem cells into insulin-producing clusters, Stem Cells, 22, 265, 10.1634/stemcells.22-3-265 · DOI · Paper page
  130. D’Amour, 2005, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat Biotechnol, 23, 1534, 10.1038/nbt1163 · DOI · Paper page
  131. Ka, 2006, Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells, Nat Biotechnol, 24, 1392, 10.1038/nbt1259 · DOI · Paper page
  132. Riedel, 2012, Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas, Diabetologia, 55, 372, 10.1007/s00125-011-2344-9 · DOI · Paper page
  133. Nostro, 2011, Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells, Development, 138, 1445, 10.1242/dev.065904 · DOI
  134. Kondo, 2017, Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells, Diabetologia, 60, 1454, 10.1007/s00125-017-4302-7 · DOI
  135. Yung, 2019, Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals, Nat Commun, 10, 4647, 10.1038/s41467-019-12624-5 · DOI
  136. Rezania, 2011, Production of functional glucagon-secreting alpha-cells from human embryonic stem cells, Diabetes, 60, 239, 10.2337/db10-0573 · DOI · Paper page
  137. Nostro, 2015, Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines, Stem Cell Rep, 4, 591, 10.1016/j.stemcr.2015.02.017 · DOI · Paper page
  138. Shim, 2007, Directed differentiation of human embryonic stem cells towards a pancreatic cell fate, Diabetologia, 50, 1228, 10.1007/s00125-007-0634-z · DOI · Paper page
  139. Rezania, 2012, Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice, Diabetes, 61, 2016, 10.2337/db11-1711 · DOI · Paper page
  140. Schulz, 2012, A scalable system for production of functional pancreatic progenitors from human embryonic stem cells, PLoS One, 7, e37004, 10.1371/journal.pone.0037004 · DOI · Paper page
  141. Jiang, 2007, Generation of insulin-producing islet-like clusters from human embryonic stem cells, Stem Cells, 25, 1940, 10.1634/stemcells.2006-0761 · DOI · Paper page
  142. Kroon, 2008, Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo, Nat Biotechnol, 26, 443, 10.1038/nbt1393 · DOI · Paper page
  143. Bruin, 2015, Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs, Stem Cell Rep, 4, 605, 10.1016/j.stemcr.2015.02.011 · DOI
  144. Henry, 2018, Initial clinical evaluation of VC-01TM combination product—a stem cell–derived islet replacement for type 1 diabetes (T1D), Diabetes, 67
  145. Shapiro, 2021, Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device, Cell Rep Med, 2, 100466, 10.1016/j.xcrm.2021.100466 · DOI · Paper page
  146. Keymeulen, 2021, Stem cell–derived islet replacement therapy (VC-02) demonstrates production of C-peptide in patients with type 1 diabetes (T1D) and hypoglycemia unawareness, Transplantation, 70
  147. Memon, 2020, Stem cell therapy for diabetes: beta cells versus pancreatic progenitors, Cells, 9, 283, 10.3390/cells9020283 · DOI
  148. Wallner, 2018, Stem cells and beta cell replacement therapy: a prospective health technology assessment study, BMC Endocr Disord, 18, 6, 10.1186/s12902-018-0233-7 · DOI · Paper page
  149. Borys, 2021, Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors, Stem Cell Res Ther, 12, 55, 10.1186/s13287-020-02109-4 · DOI
  150. Komatsu, 2017, Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival, PLoS One, 12, 10.1371/journal.pone.0183780 · DOI
  151. Bruin, 2013, Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice, Diabetologia, 56, 1987, 10.1007/s00125-013-2955-4 · DOI · Paper page
  152. Motte, 2014, Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts, Am J Physiol Endocrinol Metab, 307, E838, 10.1152/ajpendo.00219.2014 · DOI · Paper page
  153. Robert, 2019, Cell mass increase associated with formation of glucose-controlling β-cell mass in device-encapsulated implants of hiPS-derived pancreatic endoderm, Stem Cells Transl Med., 8, 1296, 10.1002/sctm.19-0043 · DOI
  154. Bruin, 2016, Hypothyroidism impairs human stem cell-derived pancreatic progenitor cell maturation in mice, Diabetes, 65, 1297, 10.2337/db15-1439 · DOI
  155. Bruin, 2015, Accelerated maturation of human stem cell-derived pancreatic progenitor cells into insulin-secreting cells in immunodeficient rats relative to mice, Stem Cell Rep, 5, 1081, 10.1016/j.stemcr.2015.10.013 · DOI
  156. Saber, 2018, Sex differences in maturation of human embryonic stem cell-derived β cells in mice, Endocrinology, 159, 1827, 10.1210/en.2018-00048 · DOI
  157. Mochida, 2020, Insulin-deficient diabetic condition upregulates the insulin-secreting capacity of human induced pluripotent stem cell–derived pancreatic endocrine progenitor cells after implantation in mice, Diabetes, 69, 634, 10.2337/db19-0728 · DOI
  158. Legøy, 2020, In vivo hyperglycaemia exposure elicits distinct period-dependent effects on human pancreatic progenitor differentiation, conveyed by oxidative stress, Acta Physiol, 228, e13433, 10.1111/apha.13433 · DOI
  159. Aguayo-Mazzucato, 2013, Thyroid hormone promotes postnatal rat pancreatic beta-cell development and glucose-responsive insulin secretion through MAFA, Diabetes, 62, 1569, 10.2337/db12-0849 · DOI
  160. Biondi, 2019, Thyroid dysfunction and diabetes mellitus: two closely associated disorders, Endocr Rev, 40, 789, 10.1210/er.2018-00163 · DOI · Paper page
  161. King, 2007, Normal relationship of beta- and non-beta-cells not needed for successful islet transplantation, Diabetes, 56, 2312, 10.2337/db07-0191 · DOI
  162. Pipeleers, 1982, Glucose-induced insulin release depends on functional cooperation between islet cells, Proc Natl Acad Sci U S A, 79, 7322, 10.1073/pnas.79.23.7322 · DOI · Paper page
  163. Holz, 1993, Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37), Nature, 361, 362, 10.1038/361362a0 · DOI · Paper page
  164. Capozzi, 2019, β Cell tone is defined by proglucagon peptides through cAMP signaling, JCI Insight, 4, e126742, 10.1172/jci.insight.126742 · DOI · Paper page
  165. Traub, 2017, Pancreatic α cell-derived glucagon-related peptides are required for β cell adaptation and glucose homeostasis, Cell Rep, 18, 3192, 10.1016/j.celrep.2017.03.005 · DOI
  166. Svendsen, 2018, Insulin secretion depends on intra-islet glucagon signaling, Cell Rep, 25, 1127, 10.1016/j.celrep.2018.10.018 · DOI · Paper page
  167. Zhu, 2019, Intra-islet glucagon signaling is critical for maintaining glucose homeostasis, JCI Insight, 5, e127994, 10.1172/jci.insight.127994 · DOI · Paper page
  168. Takeuchi, 2014, Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture, Sci Rep, 4, 4488, 10.1038/srep04488 · DOI
  169. Guaiquil, 2001, Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells, J Biol Chem, 276, 40955, 10.1074/jbc.M106878200 · DOI
  170. Russ, 2015, Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro, EMBO J, 34, 1759, 10.15252/embj.201591058 · DOI · Paper page
  171. Liu, 2021, Chemical combinations potentiate human pluripotent stem cell-derived 3D pancreatic progenitor clusters toward functional beta cells, Nat Commun, 12, 3330, 10.1038/s41467-021-23525-x · DOI
  172. Millman, 2016, Generation of stem cell-derived β-cells from patients with type 1 diabetes, Nat Commun, 159, 428
  173. Sharon, 2019, A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets, Cell, 176, 790, 10.1016/j.cell.2018.12.003 · DOI
  174. van der Meulen, 2015, Role of transcription factors in the transdifferentiation of pancreatic islet cells, J Mol Endocrinol, 54, R103, 10.1530/JME-14-0290 · DOI
  175. van der Meulen, 2012, Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic alpha and beta cells, PLoS One, 7, e52181, 10.1371/journal.pone.0052181 · DOI
  176. Sharon, 2019, Wnt signaling separates the progenitor and endocrine compartments during pancreas development, Cell Rep, 27, 2281, 10.1016/j.celrep.2019.04.083 · DOI
  177. Hannan, 2013, Generation of multipotent foregut stem cells from human pluripotent stem cells, Stem Cell Rep, 1, 293, 10.1016/j.stemcr.2013.09.003 · DOI
  178. Trott, 2017, Long-term culture of self-renewing pancreatic progenitors derived from human pluripotent stem cells, Stem Cell Rep, 8, 1675, 10.1016/j.stemcr.2017.05.019 · DOI · Paper page
  179. Gonçalves, 2021, A 3D system to model human pancreas development and its reference single-cell transcriptome atlas identify signaling pathways required for progenitor expansion, Nat Commun, 12, 3144, 10.1038/s41467-021-23295-6 · DOI
  180. Ma, 2022, Human expandable pancreatic progenitor-derived beta cells ameliorate diabetes, Sci Adv, 8, eabk1826, 10.1126/sciadv.abk1826 · DOI · Paper page
  181. Sneddon, 2012, Self-renewal of embryonic-stem-cell-derived progenitors by organ-matched mesenchyme, Nature, 491, 765, 10.1038/nature11463 · DOI
  182. Ameri, 2017, Efficient generation of glucose-responsive beta cells from isolated GP2+ human pancreatic progenitors, Cell Rep., 19, 36, 10.1016/j.celrep.2017.03.032 · DOI
  183. Kelly, 2011, Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells, Nat Biotechnol, 29, 750, 10.1038/nbt.1931 · DOI · Paper page
  184. Cogger, 2017, Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors, Nat Commun, 8, 331, 10.1038/s41467-017-00561-0 · DOI · Paper page
  185. Mahaddalkar, 2020, Generation of pancreatic beta cells from CD177(+) anterior definitive endoderm, Nat Biotechnol, 38, 1061, 10.1038/s41587-020-0492-5 · DOI · Paper page
  186. Rosado-Olivieri, 2019, YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing β cells, Nat Commun, 10, 1464, 10.1038/s41467-019-09404-6 · DOI
  187. Davis, 2020, Glucose response by stem cell-derived β cells in vitro is inhibited by a bottleneck in glycolysis, Cell Rep, 31, 107623, 10.1016/j.celrep.2020.107623 · DOI
  188. Alvarez-Dominguez, 2020, Circadian entrainment triggers maturation of human in vitro islets, Cell Stem Cell, 26, 108, 10.1016/j.stem.2019.11.011 · DOI · Paper page
  189. Gage, 2013, Initial cell seeding density influences pancreatic endocrine development during in vitro differentiation of human embryonic stem cells, PLoS One, 8, e82076, 10.1371/journal.pone.0082076 · DOI
  190. Toyoda, 2015, Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells, Stem Cell Res, 14, 185, 10.1016/j.scr.2015.01.007 · DOI
  191. Toyoda, 2017, Rho-associated kinases and non-muscle myosin IIs inhibit the differentiation of human iPSCs to pancreatic endoderm, Stem Cell Rep, 9, 419, 10.1016/j.stemcr.2017.07.005 · DOI
  192. Ghazizadeh, 2017, ROCKII inhibition promotes the maturation of human pancreatic beta-like cells, Nat Commun, 8, 298, 10.1038/s41467-017-00129-y · DOI
  193. Hogrebe, 2020, Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells, Nat Biotechnol, 38, 460, 10.1038/s41587-020-0430-6 · DOI · Paper page
  194. Lo, 2009, Ethical issues in stem cell research, Endocr Rev, 30, 204, 10.1210/er.2008-0031 · DOI · Paper page
  195. Thatava, 2013, Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells, Mol Ther, 21, 228, 10.1038/mt.2012.245 · DOI
  196. Millman, 2017, Autologous pluripotent stem cell-derived β-like cells for diabetes cellular therapy, Diabetes, 66, 1111, 10.2337/db16-1406 · DOI
  197. Zhang, 2006, Sirolimus is associated with reduced islet engraftment and impaired β-cell function, Diabetes, 55, 2429, 10.2337/db06-0173 · DOI · Paper page
  198. Zahr, 2008, Rapamycin impairs beta-cell proliferation in vivo, Transplant Proc, 40, 436, 10.1016/j.transproceed.2008.02.011 · DOI
  199. Fraenkel, 2008, mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes, Diabetes, 57, 945, 10.2337/db07-0922 · DOI · Paper page
  200. Johnson, 2009, Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets, Cell Transplant, 18, 833, 10.3727/096368909X471198 · DOI

200 of 317 shown

Cited by

See all 34

Metadata

Authors
Ramzy, A., Belmonte, P. J., Braam, M. J. S., Ida, S., Wilts, E. M., Levings, M. K., Rezania, A., & Kieffer, T. J.
Venue
Endocrine Reviews
Published
2022-09-16
Volume
44
Issue
2
Pages
222-253
ISSN
  • 0163-769X
  • 1945-7189
Cited by
34
References
58
Language
en
Funders
  • Canadian Institutes of Health Research
  • Stem Cell Network
  • Genome BC
  • JDRF
  • Vancouver Coastal Health
  • Manpei-Suzuki Diabetes foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets. https://app.cochat.ai/papers/10.1210/endrev/bnac021
The paper
Ramzy, A., Belmonte, P. J., Braam, M. J. S., Ida, S., Wilts, E. M., Levings, M. K., Rezania, A., & Kieffer, T. J. (2023). A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets. Endocrine Reviews. https://doi.org/10.1210/endrev/bnac021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.